Results 201 to 210 of about 520,129 (244)

Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy. [PDF]

BMC Pulm Med
Tang Y, Yu H, Guo S, Yao Y, Zhao J, Zheng B, Wu D, Xia Y, Wei Q, Zhang T.   +9 more
europepmc   +1 more source

Lung Cancer Patients Display Increased Expression of Bovine Meat and Milk Factor (BMMF) Proteins in Peritumor Alveolar Macrophages

International Journal of Cancer, Volume 159, Issue 8, Page 2036-2053, 15 October 2026.
Plasmid‐like DNA sequences frequently found in bovine milk and serum have been proposed as infectious agents promoting indirect carcinogenesis. This multi‐omics study detected immune cells positive for these bovine meat and milk factors (BMMFs) in patients with lung cancer, with BMMF expression inversely correlated with smoking intensity.
Nives Cecere, Kristina Alikhanyan, Claudia Ernst, Lisa Häfele, Lars Feuerbach, Imke Grewe, Sumen Siqin, Karin Gunst, Gunjan Shukla, Veronika Frehtman, Claudia Tessmer, Florian Eichhorn, Michael Allgäuer, Alexander Brobeil, Ilse Hofmann, Barbara Leuchs, Marc A. Schneider, Timo Bund   +17 more
wiley   +1 more source

Meta-analysis of the efficacy and safety of thoracic radiotherapy for extensive-stage small cell lung cancer in the era of immunotherapy. [PDF]

Oncol Lett
Jiang M, Shao L, Long Y, Sun J, Wei S.
europepmc   +1 more source

Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials

International Journal of Cancer, Volume 159, Issue 8, Page 1857-1872, 15 October 2026.
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo   +10 more
wiley   +1 more source

High-Dose Twice-Daily Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Real-World Retrospective Experience from Two Tertiary Centers. [PDF]

Onco Targets Ther
Icht O, Krayim B, Moskovitz M, Reinhorn D, Rotem O, Averbuch I, Peled N, Allen AM.   +7 more
europepmc   +1 more source

High‐Throughput Geocoding to Assess Short‐Term Air Pollution in Correlation With Mortality in a French Cancer Patient Cohort

International Journal of Cancer, Volume 159, Issue 8, Page 2054-2065, 15 October 2026.
Although chronic air pollution exposure is linked to lung cancer mortality, the short‐term effects of fluctuating air quality on overall cancer mortality remain uncertain. Here, the authors applied geomatics and machine‐learning models to retrospectively examine possible associations between 31‐day pollution exposure and mortality in a French cancer ...
Loice Pokam, Joséphine Bocquet, Nadia Hégarat, Julie Perlbarg‐Samson, Thomas Balezeau, Maud Milder, Bastien Rance, Hector Countouris, Julien Guerin, Flavien Gilles, Jean Gaudart, Nicolas Girard, Clémence Basse   +12 more
wiley   +1 more source

Timing of thoracic radiotherapy combined with immunotherapy influences pulmonary injury. [PDF]

Oncol Lett
Yuan J, Liu Q, Liu X, Zheng X, Nan X, Shi X, Zhong S, Sun B, Hao P, Wang S, Gao Y.   +10 more
europepmc   +1 more source

Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume

Journal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background In lung cancer radiotherapy, the volume of the lung receiving a dose above 20 Gy (V20Gy) and the mean lung dose are widely recognized dosimetric indicators for predicting radiation pneumonitis. However, there is currently no unified model to predict the minimum achievable values of V20Gy and mean lung dose.
Yu Wang, Deying Xu, Yunfeng Liu, Xiaofeng Zhang, Liang Yu   +4 more
wiley   +1 more source

Advancements in consolidative thoracic radiotherapy following first-line immunotherapy in conjunction with chemotherapy for extensive-stage small cell lung cancer. [PDF]

Front Immunol
Liu J, Liu J, Chen D, Zhu Y, Wu X, Cai Y.   +5 more
europepmc   +1 more source